Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02939313 · ClinicalTrials.gov registry record · Early Phase 1
Cortical rTMS as a Tool to Change Brain Reactivity to Alcohol Cues
A Early Phase 1 study, sponsored by Medical University of South Carolina.
- Completed
- Registry status
- Early Phase 1
- Development phase
- 71
- Enrollment target
NCT02939313 is a Early Phase 1 study that has completed, run by Medical University of South Carolina. The registered enrollment target is 71 participants.
The verdict
NCT02939313, a Early Phase 1 study, has completed, sponsored by Medical University of South Carolina.
- COMPLETED
- Registry status
- Early Phase 1
- Development phase
- 71 participants
- Enrollment target
Study Summary
The goal of this investigation is to determine if, in heavy alcohol users, a single session of transcranial magnetic brain stimulation (TMS) over a brain region involved in craving (medial prefrontal cortex) and a brain region involved in cogntive control (dorsolateral prefrontal cortex) can lower an individual's craving and brain response to alcohol cues. This study involves a screening visit, followed by three visits which involve brain imaging (using functional MRI) and brain stimulation (using TMS). There is also an additional Magnetic resonance spectroscopy (MRS) exploratory Aim in which we will measure the concentration of glutamate in the prefrontal cortex before and after a session of TMS.
Interventions
- DEVICE sham
- DEVICE medial prefrontal cortex
- DEVICE dorsolateral prefrontal cortex
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 71 participants |
| Start Date | 2016-01 |
| Est. Completion | 2021-04-12 |
| Phase | Early Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02939313
The ClinicalTrials.gov registry entry for NCT02939313 describes a study currently listed as completed, categorized as Early Phase 1. The registered enrollment target is 71 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Medical University of South Carolina, which has 755 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which sham is the first listed.
NCT02939313 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02939313 about?
NCT02939313 is a clinical study titled "Cortical rTMS as a Tool to Change Brain Reactivity to Alcohol Cues". The goal of this investigation is to determine if, in heavy alcohol users, a single session of transcranial magnetic brain stimulation (TMS) over a brain region involved in craving (medial prefrontal cortex) and a brain region involved in cogntive control (dorsolateral prefrontal cortex) can lower a...
What is the current status of trial NCT02939313?
This trial is currently completed. It is a Early Phase 1 study. The enrollment target is 71 participants. The study started on 2016-01. Estimated completion is 2021-04-12.
What interventions are being tested in trial NCT02939313?
The interventions under investigation include: sham (DEVICE), medial prefrontal cortex (DEVICE), dorsolateral prefrontal cortex (DEVICE).
Who is sponsoring clinical trial NCT02939313?
This trial is sponsored by Medical University of South Carolina, which has 755 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.